Target intelligence / Profile preview

First Nucleotide-Binding Domain of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR NBD1)

Target
CFTR NBD1
Molecular classification
ABC transporter domain, Nucleotide-binding domain
01

Overview

The first nucleotide-binding domain (NBD1) is one of two ATP-binding cassette (ABC) domains in the cystic fibrosis transmembrane conductance regulator (CFTR), a protein that functions as a phosphorylation- and ATP-gated chloride channel in epithelial cells. CFTR is unique among ABC transporters because it acts as an ion channel rather than a transporter, with its gating regulated by ATP binding and hydrolysis at the NBDs, and by phosphorylation events. The most prevalent mutation causing cystic fibrosis (ΔF508; deletion of phenylalanine at position 508) occurs within NBD1. This residue lies on an interface thought critical for communication between NBDs and TMDs during gating transitions. Its loss disrupts folding/stability/trafficking/functionality leading to disease phenotype.

02

Mechanism of action

ATP binding and hydrolysis modulate CFTR channel gating.

03

Biological functions

ATP bindingATP hydrolysisChloride channel gatingProtein foldingProtein trafficking
04

Disease associations

Cystic Fibrosis
05

Safety considerations

Misfolding and trafficking defects due to mutationsFunctional defects due to mutations

Beyond the preview

Go deeper on First Nucleotide-Binding Domain of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR NBD1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on First Nucleotide-Binding Domain of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR NBD1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call